Our Cell Processing Facility (CPF) is a Good Manufacturing Practice, or GMP, bioprocessing manufacturing facility that supports the reproducible production of human hematopoietic or immune-competent cells under stringent quality control and safety requirements for therapeutic studies. Our CPF team aims to consistently deliver safe and compliant cell therapy products for Phase 1/2 clinical trials.
Located in the E level of the Thomas Building, the 3,700-square-foot, controlled-access facility consists of four separate suites designed for cell culture, material preparation and various clinical processing operations. The CPF is controlled by a building management system with an independent HVAC system maintaining ISO 7 specifications.
Virtual Tour | Our Products & Process | Equipment | Process Development | Product Management
To learn more about collaborating with us, connect with our product management group. To inquire about a facility tour or to get more information about our CPF, please contact us at:
This virtual tour takes you inside the Therapeutic Products shared resource’s CPF to learn about the processes, facilities and equipment for producing high-quality cell products for clinical trials. Highlights:
Go inside the CPF and learn about our work.
The manufacturing suites that support the production of cellular therapeutics are equipped with ISO 5 biological safety cabinets and numerous double stack Thermo Steri-Cult humidified CO2 incubators. Other major equipment includes floor and tabletop centrifuges, cell washers and large-scale cell enrichment devices.
Our process development team offers expertise is all key steps in the process of developing cell-based therapies in the CPF.
These steps include cell selection, flow cytometry, cell counting and washing technologies, cytotoxicity assays, formulation and cryopreservation, viral vector transduction (static and spin-fection) and analytic development. This support is required by the Food and Drug Administration for first-in-human Phase 1/2 clinical research studies.
Process development services include the following:
Our product management team owns the process we depend on to ensure your successful IND submission, GMP-compliant manufacturing and on-time delivery of high-quality product to patients.
Complete our new clinical trial intake form to initiate a new collaboration with us.
Drawing on industry-based technical knowledge, our product management team tracks key advancements in clinical cell therapies and emerging technologies at Fred Hutch, partnering with scientific, regulatory and business development teams to assess investigator-initiated therapeutic products and outside business opportunities.
For other information about how we can work with you, contact our Technical Product Management Director, Cell Therapy, Lara Kropp.